None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and 2 BMI 18-28 kg/m2 all patients posted for laparoscopic cholecyestectomy
Exclusion criteria
Exclusion criteria: on sedatives/hypnoticspreoperatively psychiatric illness/alcohol abuse patient with known history to allergy to study drug pregnant and lactating mothers surgery duration more than 3 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to compare the analgesic effects of intravenous magnesium sulphate and inravenous ketamine in adult patients for laparoscopic cholecystectomy by NRS scoring postoperativelyTimepoint: To access pain by NRS scoring system postoperatively for first 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare the hemodynamic responsesintraoperatively with intravenous magnesium sulphate and inravenous ketamineTimepoint: intraoperatively hemodynamic response with study drug and surgery procedure less than 3 hours | — |
Countries
India
Contacts
sapthagiri institue of medical sciences bengaluru